Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-05

Clinical Trial Update: Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV [Phase 2]

View source ↗

Summary

Emory University-sponsored Phase 2 clinical trial examining the role of sympathetic overactivity and angiotensin II in post-traumatic stress disorder and cardio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Emory University | Conditions: Stress Disorders, Post-Traumatic | Phase 2 | Status: SUSPENDED